A wide range of biomaterials and engineered cell surfaces are composed of bioconjugates
embedded in liposome membranes, surface-immobilized bilayers, or the plasma …

Cornea is the major barrier to drug delivery to the eye, which results in low bioavailability
and poor efficacy of topical eye treatment. In this work, we first select cornea‐binding …

The antimicrobial resistance crisis requires novel approaches for the therapy of infections
especially with Gram-negative pathogens. Pseudomonas aeruginosa is defined as priority 1 …

The global threat posed by antimicrobial resistance demands urgent action and the
development of effective drugs. Lower respiratory tract infections remain the deadliest …

The inflammatory response is the basis of many diseases, such as atherosclerosis and
ulcerative colitis. Inhibiting inflammatory response is the key to treating these diseases …

We created valrubicin-loaded immunoliposomes (Val-ILs) using the antitumor prodrug
valrubicin, a hydrophobic analog of daunorubicin. Being lipophilic, valrubicin readily …

The recent novel approach of third level drug targeting directly within the intracellular
locations can enhance the efficiency of treatment procedures to new heights. Cells usually …

Displaying antibodies on carrier surfaces facilitates precise targeting and delivery of drugs to
diseased cells. Here, we report the synthesis of antibody-lipid conjugates (ALCs) through …

The liposome particle size is an important parameter because it strongly affects content
release from liposomes as a result of different bilayer curvatures and lipid packing. Earlier …

Acinetobacter baumannii infections have come to the surface in huge numbers in the recent
decades. Furthermore, A. baumannii has adopted great ability to nullify the majority of …